Figure 3: Dose-dependent inhibition of monocyte and DC activation by FP7. | Scientific Reports

Figure 3: Dose-dependent inhibition of monocyte and DC activation by FP7.

From: TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection

Figure 3

Human monocytes (a–c) or DCs (d–f) were stimulated for 24 h with 10 ng/ml LPS, in the absence or presence of increasing amounts FP7. IL-8, MIP-1β, and IL-6 were assayed in supernatants of a representative experiment. *P < 0.05 compared to LPS-stimulated cells.

Back to article page